Compile Data Set for Download or QSAR
maximum 50k data
Found 671 with Last Name = 'dickinson' and Initial = 'rp'
Target72 kDa type IV collagenase(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50062351((R)-N*4*-Hydroxy-N*1*-[(S)-2-(1H-indol-3-yl)-1-met...)
Affinity DataKi:  0.570nMAssay Description:Inhibition of Matrix metalloproteinase-2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16171(2-[4-chloro-7-({1-[(4-methylpiperazin-1-yl)carbony...)
Affinity DataKi:  1.40nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16170(2-(4-chloro-7-{[1-(morpholin-4-ylcarbonyl)cyclopen...)
Affinity DataKi:  1.60nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16165(1-({4-chloro-1-[(diaminomethylidene)amino]isoquino...)
Affinity DataKi:  2.60nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16154(1-({4-chloro-1-[(diaminomethylidene)amino]isoquino...)
Affinity DataKi:  5.80nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16156(4-({4-chloro-1-[(diaminomethylidene)amino]isoquino...)
Affinity DataKi:  7.40nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16153(1-({4-chloro-1-[(diaminomethylidene)amino]isoquino...)
Affinity DataKi:  7.40nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16155(1-({4-chloro-1-[(diaminomethylidene)amino]isoquino...)
Affinity DataKi:  8nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM50147416(3-(4-Chloro-1-guanidino-isoquinolin-7-yl)-4-methox...)
Affinity DataKi:  9nMAssay Description:Inhibitory activity against human urokinase-type plasminogen activator was evaluated using S-2444 as substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16159((2R)-1-({4-chloro-1-[(diaminomethylidene)amino]iso...)
Affinity DataKi:  9.90nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16169(1-({4-chloro-1-[(diaminomethylidene)amino]isoquino...)
Affinity DataKi:  10nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16152(2-({4-chloro-1-[(diaminomethylidene)amino]isoquino...)
Affinity DataKi:  10nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16164(1-({4-chloro-1-[(diaminomethylidene)amino]isoquino...)
Affinity DataKi:  11nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16157(4-({4-chloro-1-[(diaminomethylidene)amino]isoquino...)
Affinity DataKi:  11nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16166(cycloleucine deriv. 40 | ethyl 1-({4-chloro-1-[(di...)
Affinity DataKi:  14nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16129(1-isoquinolinylguanidine 3 | 3-{4-chloro-1-[(diami...)
Affinity DataKi:  17nM ΔG°:  -46.1kJ/molepH: 8.1 T: 2°CAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16148((2R)-2-({4-chloro-1-[(diaminomethylidene)amino]iso...)
Affinity DataKi:  19nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16147((2S)-2-({4-chloro-1-[(diaminomethylidene)amino]iso...)
Affinity DataKi:  21nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16150((2R)-2-({4-chloro-1-[(diaminomethylidene)amino]iso...)
Affinity DataKi:  22nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16161((2R)-1-({4-chloro-1-[(diaminomethylidene)amino]iso...)
Affinity DataKi:  23nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetStromelysin-1(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50062351((R)-N*4*-Hydroxy-N*1*-[(S)-2-(1H-indol-3-yl)-1-met...)
Affinity DataKi:  26nMAssay Description:Inhibition of Matrix metalloproteinase-3More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16151((2S)-2-[benzyl({4-chloro-1-[(diaminomethylidene)am...)
Affinity DataKi:  27nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16146((2R)-2-({4-chloro-1-[(diaminomethylidene)amino]iso...)
Affinity DataKi:  28nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16143(2-({4-chloro-1-[(diaminomethylidene)amino]isoquino...)
Affinity DataKi:  29nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16168(1-({4-chloro-1-[(diaminomethylidene)amino]isoquino...)
Affinity DataKi:  30nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50097248((R)-N*4*-Hydroxy-N*1*-[(S)-1-((S)-indan-1-ylcarbam...)
Affinity DataKi:  30nMAssay Description:Inhibition of Matrix metalloproteinase-2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16145(2-({4-chloro-1-[(diaminomethylidene)amino]isoquino...)
Affinity DataKi:  31nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16144(2-[benzyl({4-chloro-1-[(diaminomethylidene)amino]i...)
Affinity DataKi:  35nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM50147422(3-(4-Chloro-1-guanidino-isoquinolin-7-yl)-benzoic ...)
Affinity DataKi:  37nMAssay Description:Inhibitory activity against human urokinase-type plasminogen activator was evaluated using S-2444 as substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16141(1-guanidino-7-sulfonamidoisoquinoline 15 | 3-({4-c...)
Affinity DataKi:  43nM ΔG°:  -43.7kJ/molepH: 8.1 T: 2°CAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16139(1-guanidino-7-sulfonamidoisoquinoline 13 | 2-({4-c...)
Affinity DataKi:  48nM ΔG°:  -43.5kJ/molepH: 8.1 T: 2°CAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16163((2R)-1-({4-chloro-1-[(diaminomethylidene)amino]iso...)
Affinity DataKi:  54nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16142(2-({4-chloro-1-[(diaminomethylidene)amino]isoquino...)
Affinity DataKi:  54nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16140(1-guanidino-7-sulfonamidoisoquinoline 14 | 3-({4-c...)
Affinity DataKi:  58nM ΔG°:  -43.0kJ/molepH: 8.1 T: 2°CAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16138(1-guanidino-7-sulfonamidoisoquinoline 12 | 3-({4-c...)
Affinity DataKi:  59nM ΔG°:  -42.9kJ/molepH: 8.1 T: 2°CAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16149((2S)-2-({4-chloro-1-[(diaminomethylidene)amino]iso...)
Affinity DataKi:  66nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16167(2-(4-chloro-7-{[1-(hydroxymethyl)cyclopentyl]sulfa...)
Affinity DataKi:  67nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16133(1-guanidino-7-sulfonamidoisoquinoline 7 | 2-[4-chl...)
Affinity DataKi:  71nM ΔG°:  -42.4kJ/molepH: 8.1 T: 2°CAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM50147424(4-(4-Chloro-1-guanidino-isoquinolin-7-yl)-benzoic ...)
Affinity DataKi:  82nMAssay Description:Inhibitory activity against human urokinase-type plasminogen activator was evaluated using S-2444 as substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM50147419(CHEMBL320729 | N-[4-Chloro-7-(3-methoxy-phenyl)-is...)
Affinity DataKi:  83nMAssay Description:Inhibitory activity against human urokinase-type plasminogen activator was evaluated using S-2444 as substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16137(1-guanidino-7-sulfonamidoisoquinoline 11 | 2-({4-c...)
Affinity DataKi:  86nM ΔG°:  -42.0kJ/molepH: 8.1 T: 2°CAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetStromelysin-1(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50097248((R)-N*4*-Hydroxy-N*1*-[(S)-1-((S)-indan-1-ylcarbam...)
Affinity DataKi:  93nMAssay Description:Inhibition of Matrix metalloproteinase-3More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50097257((R)-N*4*-Hydroxy-N*1*-[(S)-1-((R)-indan-1-ylcarbam...)
Affinity DataKi:  100nMAssay Description:Inhibition of Matrix metalloproteinase-2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM50147423(CHEMBL432422 | N-(7-Benzo[1,3]dioxol-5-yl-4-chloro...)
Affinity DataKi:  100nMAssay Description:Inhibitory activity against human urokinase-type plasminogen activator was evaluated using S-2444 as substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM50147418(CHEMBL320493 | N-[4-Chloro-7-(2-methoxy-phenyl)-is...)
Affinity DataKi:  100nMAssay Description:Inhibitory activity against human urokinase-type plasminogen activator was evaluated using S-2444 as substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16160((2S)-1-({4-chloro-1-[(diaminomethylidene)amino]iso...)
Affinity DataKi:  111nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16134(1-guanidino-7-sulfonamidoisoquinoline 8 | 2-[4-chl...)
Affinity DataKi:  130nM ΔG°:  -40.9kJ/molepH: 8.1 T: 2°CAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM50147415(CHEMBL109274 | N-(4-Chloro-7-p-tolyl-isoquinolin-1...)
Affinity DataKi:  130nMAssay Description:Inhibitory activity against human urokinase-type plasminogen activator was evaluated using S-2444 as substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16132(1-guanidino-7-sulfonamidoisoquinoline 6 | 2-(4-chl...)
Affinity DataKi:  140nM ΔG°:  -40.7kJ/molepH: 8.1 T: 2°CAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

LigandPNGBDBM16162(2-(4-chloro-7-{[(2R)-2-(hydroxymethyl)pyrrolidine-...)
Affinity DataKi:  160nMAssay Description:Ki values for compounds were calculated by incubation of each enzyme with its substrate and various compound concentrations. Absorbance was read at 4...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 671 total ) | Next | Last >>
Jump to: